Henry L. Keen
- Molecular Biology top 10%
- Physiology top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Biochemistry top 2%
- Co-authors
- Curt D. SigmundFrank M. FaraciJohn E. HallWillem J. de LangeMichael W. BrandsAndreas BeyerCarmen M. HalabiChristopher J. Pelham
- Topics
- Peroxisome Proliferator-Activated Receptors (16 papers)Receptor Mechanisms and Signaling (10 papers)Renin-Angiotensin System Studies (10 papers)
- Partner nations
- United StatesSingaporeRussia
In The Last Decade
Henry L. Keen
59 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 794
- Physiology 479
- Cardiology and Cardiovascular Medicine 448
- Endocrinology, Diabetes and Metabolism 433
- Biochemistry 213
Countries citing papers authored by Henry L. Keen
This map shows the geographic impact of Henry L. Keen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry L. Keen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry L. Keen more than expected).
Fields of papers citing papers by Henry L. Keen
This network shows the impact of papers produced by Henry L. Keen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry L. Keen. The network helps show where Henry L. Keen may publish in the future.
Co-authorship network of co-authors of Henry L. Keen
This figure shows the co-authorship network connecting the top 25 collaborators of Henry L. Keen. A scholar is included among the top collaborators of Henry L. Keen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry L. Keen. Henry L. Keen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 0 | |
| 7 | 25 | |
| 8 | 5 | |
| 9 | 24 | |
| 10 | 53 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 53 | |
| 14 | 95 | |
| 15 | 142 | |
| 16 | 3 | |
| 17 | 23 | |
| 18 | 21 | |
| 19 | 37 | |
| 20 | 60 |
About Henry L. Keen
Henry L. Keen is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 62 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (16 papers), Receptor Mechanisms and Signaling (10 papers) and Renin-Angiotensin System Studies (10 papers). The work is most often cited by research in Biochemistry (213 citations), Endocrinology, Diabetes and Metabolism (433 citations) and Cardiology and Cardiovascular Medicine (448 citations). Henry L. Keen has collaborated with scholars based in United States, Singapore and Russia. Frequent co-authors include Curt D. Sigmund, Frank M. Faraci, John E. Hall, Willem J. de Lange, Michael W. Brands, Andreas Beyer, Carmen M. Halabi, Christopher J. Pelham, Pimonrat Ketsawatsomkron and Justin L. Grobe. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.